TIDMGSK

RNS Number : 6485Q

GlaxoSmithKline PLC

20 February 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ================================================================================= 
 a)    Name                      Mr J Ford 
====  =========================  ====================================================== 
 b)    Position/status           SVP & General Counsel 
====  =========================  ====================================================== 
 c)    Initial notification/     Initial notification 
        amendment 
====  =========================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ================================================================================= 
 a)    Name                      GlaxoSmithKline plc 
====  =========================  ====================================================== 
 b)    LEI                       5493000HZTVUYLO1D793 
====  =========================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ================================================================================= 
 a)    Description of             GlaxoSmithKline plc American Depositary 
        the financial              Shares ('ADSs') 
        instrument                 ISIN: US37733W1053 
====  =========================  ====================================================== 
 b)    Nature of the             The exercise of options over 11,870 ADSs, 
        transaction               granted on 22 February 2010 under the GlaxoSmithKline 
                                  Share Option Plan, at an option price of 
                                  $37.32. 
====  =========================  ====================================================== 
 c)    Price(s) and                Price(s)   Volume(s) 
        volume(s)                   $37.32     2,679 (Incentive Stock 
                                                Option) 
                                              --------------------------- 
                                    $37.32     9,191 (Non-Qualified Stock 
                                                Option) 
                                              --------------------------- 
====  =========================  ====================================================== 
 d)    Aggregated information 
   Aggregated volume 
    Price 
 
 
                                  11,870 
                                   $37.32 
 ==============================  ====================================================== 
 e)    Date of the transaction   2019-02-19 
====  =========================  ====================================================== 
 f)    Place of the              n/a 
        transaction 
====  =========================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ==================================================================== 
 a)    Name                       Mr J Ford 
====  ==========================  ======================================== 
 b)    Position/status            SVP & General Counsel 
====  ==========================  ======================================== 
 c)    Initial notification/      Initial notification 
        amendment 
====  ==========================  ======================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ==================================================================== 
 a)    Name                       GlaxoSmithKline plc 
====  ==========================  ======================================== 
 b)    LEI                        5493000HZTVUYLO1D793 
====  ==========================  ======================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ==================================================================== 
 a)    Description of              GlaxoSmithKline plc American Depositary 
        the financial               Shares ('ADSs') 
        instrument                  ISIN: US37733W1053 
====  ==========================  ======================================== 
 b)    Nature of the              The sale of 11,870 ADSs, granted on 22 
        transaction                February 2010 under the GlaxoSmithKline 
                                   Share Option Plan. 
====  ==========================  ======================================== 
 c)    Price(s) and                 Price(s)   Volume(s) 
        volume(s)                    $41.22     2,679 (Incentive Stock 
                                                 Option) 
                                               --------------------------- 
                                     $41.22     9,191 (Non-Qualified Stock 
                                                 Option) 
                                               --------------------------- 
====  ==========================  ======================================== 
 d)    Aggregated information 
   Aggregated volume 
    Price 
 
 
                                   11,870 
                                    $41.22 
 ===============================  ======================================== 
 e)    Date of the transaction    2019-02-19 
====  ==========================  ======================================== 
 f)    Place of the               New York Stock Exchange (XNYS) 
        transaction 
====  ==========================  ======================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     =================================================================== 
 a)   Name                      Mr J Ford 
===  =========================  ======================================== 
 b)   Position/status           SVP & General Counsel 
===  =========================  ======================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  ======================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  ======================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  ======================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =================================================================== 
 a)   Description of             GlaxoSmithKline plc American Depositary 
       the financial              Shares ('ADSs') 
       instrument                 ISIN: US37733W1053 
===  =========================  ======================================== 
 b)   Nature of the             The sale of ADSs 
       transaction 
===  =========================  ======================================== 
 c)   Price(s) and                Price(s)   Volume(s) 
       volume(s)                   $41.22     11,884 
                                             ---------- 
===  =========================  ======================================== 
 d)   Aggregated information    n/a (single transaction) 
       Aggregated volume 
       Price 
===  =========================  ======================================== 
 e)   Date of the transaction   2019-02-19 
===  =========================  ======================================== 
 f)   Place of the              New York Stock Exchange (XNYS) 
       transaction 
===  =========================  ======================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr J Ford 
===  ========================  ============================================ 
 b)   Position/status          SVP & General Counsel 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 

 b)   Nature of the            Sale of Ordinary Shares 
       transaction 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                             ---------- 
                                  GBP15.66    1 
                                             ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-02-19 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHZBLFLKLFXBBK

(END) Dow Jones Newswires

February 20, 2019 09:44 ET (14:44 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Gsk.